Continue Reading
Full article on Bloomberg
AstraZeneca Shares to Start Trading in US After Listing Upgrade
Market Intelligence Analysis
AI-Powered
Why This Matters
AstraZeneca's shares will begin trading on the New York Stock Exchange, replacing its existing American Depositary Receipts on Nasdaq, as part of a listing upgrade.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Shares of AstraZeneca Plc, the UK’s biggest drugmaker, will start trading on the New York Stock Exchange on Monday following a listing upgrade to replace its American Depositary Receipts that were on Nasdaq.
Original article published by
Bloomberg
on February 2, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.